title: Mild gestational hyperglycemia in rat induces fetal overgrowth and modulates placental growth factors and nutrient transporters expression.
abstract: Mild gestational hyperglycemia is often associated with fetal overgrowth that can predispose the offspring to metabolic diseases later in life. We hypothesized that unfavorable intrauterine environment may compromise the development of placenta and contribute to fetal overgrowth. Therefore, we developed a rat model and investigated the effects of maternal dysglycemia on fetal growth and placental gene expression. Female rats were treated with single injection of nicotinamide plus streptozotocin (N-STZ) 1-week before mating and were studied at gestational day 21. N-STZ pregnant females displayed impaired glucose tolerance that is associated with a lower insulin secretion. Moderate hyperglycemia induced fetal overgrowth in 40% of newborns, from pregnancies with 10 to 14 pups. The incidence of macrosomia was less than 5% in the N-STZ pregnancies when the litter size exceeds 15 newborns. We found that placental mass and the labyrinthine layer were increased in macrosomic placentas. The expression of genes involved in placental development and nutrient transfer was down regulated in the N-STZ placentas of macrosomic and normosomic pups from pregnancies with 10 to 14 ones. However, we observed that lipoprotein lipase 1 (LPL1) gene expression was significantly increased in the N-STZ placentas of macrosomic pups. In pregnancies with 15 pups or more, the expression of IGFs and glucose transporter genes was also modulated in the control placentas with no additional effect in the N-STZ ones. These data suggest that placental gene expression is modulated by gestational conditions that might disrupt the fetal growth. We described here a new model of maternal glucose intolerance that results in fetal overgrowth. We proposed that over-expression of LPL1 in the placenta may contribute to the increased fetal growth in the N-STZ pregnancies. N-STZ model offers the opportunity to determinate whether these neonatal outcomes may contribute to developmental programming of metabolic diseases in adulthood.
authors.affiliation: Unité Environnement Périnatal et Croissance, EA 4489, Université Lille Nord de France, Lille, France.
authors.forename: Ouma
authors.initials: O
authors.lastname: Cisse
authors.forename: Isabelle
authors.initials: I
authors.lastname: Fajardy
authors.forename: Anne
authors.initials: A
authors.lastname: Dickes-Coopman
authors.forename: Emmanuelle
authors.initials: E
authors.lastname: Moitrot
authors.forename: Valérie
authors.initials: V
authors.lastname: Montel
authors.forename: Sylvie
authors.initials: S
authors.lastname: Deloof
authors.forename: Jean
authors.initials: J
authors.lastname: Rousseaux
authors.forename: Didier
authors.initials: D
authors.lastname: Vieau
authors.forename: Christine
authors.initials: C
authors.lastname: Laborie
mesh_terms: D000818:Animals; D001724:Birth Weight; D005260:Female; D047109:Fetal Development; D005328:Fetal Viability; D018507:Gene Expression Regulation, Developmental; D051246:Glucose Transport Proteins, Facilitative / Q000235:genetics / Q000378:metabolism*; D006943:Hyperglycemia; D008071:Lipoprotein Lipase / Q000378:metabolism; D008098:Litter Size; D010920:Placenta / Q000378:metabolism*; D000072483:Placenta Growth Factor; D011247:Pregnancy; D011248:Pregnancy Complications; D011257:Pregnancy Proteins / Q000235:genetics / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D051246:Glucose Transport Proteins, Facilitative; C000608038:Pgf protein, rat; D011257:Pregnancy Proteins; D000072483:Placenta Growth Factor; D008071:Lipoprotein Lipase